Dow Down 1.60% Nasdaq Down 0.39%

More On ITMN

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(ITMN)

-NasdaqGS
0.00 0.00(0.00%) N/A
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:65.73
Beta:3.61
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:32.29 - 74.24
Volume:0
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-2.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Sep-14) :N/A
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

InterMune, Inc., a biotechnology company, focuses on the research, development, and commercialization of therapies for pulmonology and orphan fibrotic diseases in North America and Europe. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback